Biosimilar Newsletter Archive

51. 06.06.24 -- Accelerate The mAb Formulation Process 6/6/2024
    06/06/24 Biosimilar Development Newsletter
52. 05.30.24 -- Injectable Medications: How To Stay Relevant & Patient Centric 5/30/2024
    05/30/24 Biosimilar Development Newsletter
53. 05.23.24 -- Minimize Waste, Maximize Yield And Supor Charge Your Production Process 5/23/2024

    05/23/24 Biosimilar Development Newsletter

54. 05.23.24 -- Tech Advancements For Upstream Bioprocessing 5/23/2024
    05/23/24 Biosimilar Development Newsletter
55. 05.16.24 -- Integrating Quality Processes And Documentation After A Merger 5/16/2024
    05/16/24 Biosimilar Development Newsletter
56. 05.14.24 -- Let's deviate from deviations - Sterile drugs. 5/14/2024

    05/14/24 Biosimilar Development Newsletter

57. 05.09.24 -- Sandoz, Amgen Resolve Denosumab Patent Litigation 5/9/2024
    05/09/24 Biosimilar Development Newsletter
58. 05.02.24 -- Designing Highly Agile Biopharma Manufacturing Facilities 5/2/2024
    05/02/24 Biosimilar Development Newsletter
59. 04.25.24 -- How Continuous Manufacturing Is Shaping Biopharma 4/25/2024
    04/25/24 Biosimilar Development Newsletter
60. 04.23.24 -- Novel Approaches In Chromatography Process Development 4/23/2024

    04/23/24 Biosimilar Development Newsletter